Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

A main obstacle to an HIV cure is that viral DNA integrates into the chromosomes of memory T cells (blue), which evade ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...

Named after Indiana teenager Ryan White – who contracted HIV in 1984 after receiving an untested blood transfusion while ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

King Holmes, MD, PhD, an infectious diseases physician and researcher who helped create modern STI research and was a central figure in the early AIDS ... of HIV after receiving stem cell ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.